Cargando…

Plasma complement component 4 increases in patients with major depressive disorder

Elevation of plasma inflammatory factors in major depressive disorder (MDD) has been repeatedly observed, but contradictory results have also been reported. Alteration of complement components in MDD may also contribute to the pathophysiology of MDD by participating in inflammation. The recent findi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Jinxue, Liu, Ye, Zhao, Liansheng, Yang, Xiao, Ni, Peiyan, Wang, Yingcheng, Li, Tao, Ma, Xiaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741988/ https://www.ncbi.nlm.nih.gov/pubmed/29302190 http://dx.doi.org/10.2147/NDT.S151238

Ejemplares similares

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
por: Wang, Min, et al.
Publicado: (2019)

Disrupted association between structural and functional coupling of the supplementary motor area and neurocognition in major depressive disorder
por: Wei, Jinxue, et al.
Publicado: (2023)

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
por: Yu, Hua, et al.
Publicado: (2023)

Plasma metabolites were associated with spatial working memory in major depressive disorder
por: Du, Yue, et al.
Publicado: (2021)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-naïve patients with first-episode schizophrenia
por: Yu, Hua, et al.
Publicado: (2023)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni, Peiyan, et al.
Publicado: (2021)

A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder
por: Wang, Yu, et al.
Publicado: (2022)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang, Xiao, et al.
Publicado: (2015)

Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles
por: Tao, Shiwan, et al.
Publicado: (2022)

Valproate Reverses Mania-Like Behavior of Clock(delta19) Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus
por: Liu, Shasha, et al.
Publicado: (2021)

Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma
por: Luo, Xianmei, et al.
Publicado: (2022)

Increased miR-132 level is associated with visual memory dysfunction in patients with depression
por: Liu, Ye, et al.
Publicado: (2016)

Sex differences in the clinical characteristics and brain gray matter volume alterations in unmedicated patients with major depressive disorder
por: Yang, Xiao, et al.
Publicado: (2017)

Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder
por: Pillai, Anilkumar, et al.
Publicado: (2019)

Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development
por: Wang, Qiang, et al.
Publicado: (2015)

Is serum complement C1q related to major depressive disorder?
por: Yang, Jing, et al.
Publicado: (2020)

High level of pattern glare in major depressive disorder
por: Qi, Xiongwei, et al.
Publicado: (2019)

Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Influence of splenectomy on immunoglobulins and complement components in major thalassemia
por: Darzi, Ali Asghar, et al.
Publicado: (2015)

The pattern glare and visual memory are disrupted in patients with major depressive disorder
por: Wang, Min, et al.
Publicado: (2022)

Multiple Complement Pathway-related Proteins Might Regulate Immunopathogenesis of Major Depressive Disorder
por: Reddy, Preethi V., et al.
Publicado: (2023)

Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder
por: Lu, Yun-Rong, et al.
Publicado: (2014)

Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome
por: Taylor, Bryn C., et al.
Publicado: (2023)

Increased risk of major depressive disorder in sleep apnea patients in Taiwan
por: Chen, Chia-Min, et al.
Publicado: (2021)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Lee, Hyunju, et al.
Publicado: (2021)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
por: Sorri, Annamari, et al.
Publicado: (2021)

Assessment of Complement Cascade Components in Patients With Bipolar Disorder
por: Reginia, Artur, et al.
Publicado: (2018)

Increased cerebrospinal fluid fibrinogen in major depressive disorder
por: Hattori, Kotaro, et al.
Publicado: (2015)

Edible Mushrooms as a Potential Component of Dietary Interventions for Major Depressive Disorder
por: Fijałkowska, Agata, et al.
Publicado: (2022)

Brain connectivity in major depressive disorder: a precision component of treatment modalities?
por: Tura, Asude, et al.
Publicado: (2023)

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui, Si-Wen, et al.
Publicado: (2018)

Changes in Regional Homogeneity of Medication-Free Major Depressive Disorder Patients With Different Onset Ages
por: Zhang, Zijian, et al.
Publicado: (2021)

Increased activation product of complement 4 protein in plasma of individuals with schizophrenia
por: Kalinowski, Agnieszka, et al.
Publicado: (2021)

Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
por: Lu, Shaojia, et al.
Publicado: (2022)

T21. ALTERATIONS OF CRY2 AND PER3 GENE EXPRESSION ARE ASSOCIATED WITH GRAY MATTER ABNORMALITIES OF THALAMIC-LIMBIC NETWORK IN UNIPOLAR DEPRESSION AND BIPOLAR DEPRESSION
por: Zhang, Chengcheng, et al.
Publicado: (2018)

Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit
Publicado: (1981)

Increased Amygdala Response to Shame in Remitted Major Depressive Disorder
por: Pulcu, Erdem, et al.
Publicado: (2014)

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
por: Gracias, Jessica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ohrkbnti8eej306o6q8qneuegd